All news articles for November 2017

(Image: iStock/AlexRaths)

Non-animal testing lab opens in China

By Melissa Fassbender

A Chinese regulatory institute has opened a non-animal testing laboratory – a model for regulatory bodies at large that implementing alternative methods into government laboratories is achievable, says IIVS president.

(Image: iStock/Ridofranz)

Avantor completes $6.5bn VWR acquisition

By Melissa Fassbender

Avantor, Inc. has completed its previously announced acquisition of VWR Corporation to create a global provider of “discovery-to-delivery” solutions, says CEO.


UK drug development firm RxCelerate expands in US

By Flora Southey

Contract drug developer RxCelerate has opened an office in Massachusetts to expand its medicinal chemistry, antibody discovery, and preclinical safety services throughout North America.

(Image: Getty/BrianAJackson)

AAPS 2017

Quality-by-design: How to mitigate risk in drug development

By Melissa Fassbender

As the industry continues to externalize components of the supply chain, global regulatory authorities are requiring a “quality-by-design” (QbD) approach to help mitigate risk across the drug development process.